Last reviewed · How we verify

NCT03121911

Effects of Interval Physical Training on Expiratory Flow Limitation in Recent Myocardial Infarction

Withdrawn NA Last updated 5 May 2020
What this trial tests

NA trial testing Interval Training (IT) in Expiratory Flow Limitation. Withdrawn.

Timeline
4 July 2019
Primary endpoint
28 February 2021
31 October 2022

Quick facts

Lead sponsorFederal University of Uberlandia
PhaseNA
StatusWithdrawn
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Start date4 July 2019
Primary completion28 February 2021
Estimated completion31 October 2022
Sites1 location across Brazil

Drugs / interventions tested

Conditions studied

Sponsor

Federal University of Uberlandia

Who can join

Adults 35 to 80, male only, with Expiratory Flow Limitation or Recent Myocardial Infarction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Introduction: Expiratory flow limitation (EFL) and ventilatory inefficiency during dynamic exercise have been identified in patients with recent myocardial infarction (RMI) with preserved ventricular and pulmonary function. However, it is not known what is the prevalence of EFL in this population and what are the effects of physical and respiratory training on this limitation. Objectives: To evaluate the prevalence of EFL and ventilatory inefficiency during dynamic exercise in individuals with uncomplicated RMI, and to evaluate the effects of interval physical training (IT) in addition to inspiratory muscle training (IMT), exclusive IT and absence of cardiopulmonary rehabilitation (CR) on EFL and ventilatory efficiency. Methods: 54 patients will be included, divided into three groups with 18 participants each. All will be submitted to evaluations of heart rate variability, hematological and biochemical profile, erythrocytes membrane deformability and stability, inflammatory markers, respiratory pressures, plethysmography, spirometry, carbon monoxide diffusion capacity, ankle brachial index, electrical bioimpedance, echocardiogram, quality of life questionnaires, cardiopulmonary exercise testing and constant load tests. Then, groups 1 (IT) and group 2 (IT + IMT) will participate in a physical training program for 12 weeks and will be re-evaluated after this period. In addition, they will be monitored for a 6 month period after discharge, with returns every two months to measure the energy expenditure through an accelerometer, and at the end of this period they will repeat all the tests again. Group 3 (absence of CR), will consist of patients who do not live in the city or those who can not participate in the CR program for any other reason, and will only participate in the evaluations.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Federal University of Uberlandia trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03121911.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing